Castle Biosciences Stock Performance

CSTL Stock  USD 32.23  0.52  1.59%   
The firm shows a Beta (market volatility) of 0.73, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Castle Biosciences' returns are expected to increase less than the market. However, during the bear market, the loss of holding Castle Biosciences is expected to be smaller as well. At this point, Castle Biosciences has a negative expected return of -0.0935%. Please make sure to confirm Castle Biosciences' value at risk, as well as the relationship between the skewness and day median price , to decide if Castle Biosciences performance from the past will be repeated at some point in the near future.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days Castle Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Castle Biosciences is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors. ...more

Actual Historical Performance (%)

One Day Return
(1.59)
Five Day Return
(7.86)
Year To Date Return
(16.37)
Ten Year Return
50.61
All Time Return
50.61
1
Castle Biosciences to Present at the Piper Sandler 37th Annual Healthcare Conference
11/11/2025
2
Disposition of 2678 shares by Derek Maetzold of Castle Biosciences at 34.02 subject to Rule 16b-3
11/18/2025
3
Disposition of 2678 shares by Derek Maetzold of Castle Biosciences at .23 subject to Rule 16b-3
12/02/2025
4
Disposition of 13 shares by Derek Maetzold of Castle Biosciences at 40.03 subject to Rule 16b-3
12/04/2025
5
Disposition of 4496 shares by Frank Stokes of Castle Biosciences at 37.45 subject to Rule 16b-3
12/11/2025
6
GILD Exercises Option to License Assembly Bios Herpes Programs
12/23/2025
7
Disposition of 13181 shares by Derek Maetzold of Castle Biosciences at 38.25 subject to Rule 16b-3
12/26/2025
8
Disposition of 13 shares by Derek Maetzold of Castle Biosciences at 40.096 subject to Rule 16b-3
01/06/2026
9
Castle Biosciences Valuation After Upgraded 2025 Guidance And Strong Core Test Volume Growth
01/12/2026
10
Castle Biosciences Valuation After Upgraded Guidance And Higher Analyst Growth Expectations
01/16/2026
11
Castle Biosciences Hits New 12-Month High - Whats Next - MarketBeat
01/22/2026
12
Castle Biosciences price target raised to 50 from 36 at KeyBanc - TipRanks
01/29/2026
13
Disposition of 3200 shares by Derek Maetzold of Castle Biosciences at .913 subject to Rule 16b-3
02/03/2026
14
Disposition of 171 shares by Derek Maetzold of Castle Biosciences at 38.61 subject to Rule 16b-3
02/04/2026
15
Castle Biosciences Loses 16.8 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner
02/09/2026
Begin Period Cash Flow98.8 M
Total Cashflows From Investing Activities-50.1 M

Castle Biosciences Relative Risk vs. Return Landscape

If you would invest  3,482  in Castle Biosciences on November 12, 2025 and sell it today you would lose (259.00) from holding Castle Biosciences or give up 7.44% of portfolio value over 90 days. Castle Biosciences is currently does not generate positive expected returns and assumes 2.6426% risk (volatility on return distribution) over the 90 days horizon. In different words, 23% of stocks are less volatile than Castle, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon.
  Expected Return   
       Risk  
Given the investment horizon of 90 days Castle Biosciences is expected to under-perform the market. In addition to that, the company is 3.26 times more volatile than its market benchmark. It trades about -0.04 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.08 per unit of volatility.

Castle Biosciences Target Price Odds to finish over Current Price

The tendency of Castle Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 32.23 90 days 32.23 
about 98.0
Based on a normal probability distribution, the odds of Castle Biosciences to move above the current price in 90 days from now is about 98.0 (This Castle Biosciences probability density function shows the probability of Castle Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Castle Biosciences has a beta of 0.73 suggesting as returns on the market go up, Castle Biosciences average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Castle Biosciences will be expected to be much smaller as well. Additionally Castle Biosciences has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   Castle Biosciences Price Density   
       Price  

Predictive Modules for Castle Biosciences

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Castle Biosciences. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Castle Biosciences' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
29.4932.1334.77
Details
Intrinsic
Valuation
LowRealHigh
29.0137.5040.14
Details
9 Analysts
Consensus
LowTargetHigh
44.2048.5753.91
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.41-0.33-0.23
Details

Castle Biosciences Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. Castle Biosciences is not an exception. The market had few large corrections towards the Castle Biosciences' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Castle Biosciences, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Castle Biosciences within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.0087
β
Beta against Dow Jones0.73
σ
Overall volatility
2.86
Ir
Information ratio -0.01

Castle Biosciences Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Castle Biosciences for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Castle Biosciences can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
Castle Biosciences generated a negative expected return over the last 90 days
Over 91.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Castle Biosciences Loses 16.8 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner

Castle Biosciences Price Density Drivers

Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Castle Stock often depends not only on the future outlook of the current and potential Castle Biosciences' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Castle Biosciences' indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding29.3 M
Cash And Short Term Investments293.1 M

Castle Biosciences Fundamentals Growth

Castle Stock prices reflect investors' perceptions of the future prospects and financial health of Castle Biosciences, and Castle Biosciences fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Castle Stock performance.

About Castle Biosciences Performance

By examining Castle Biosciences' fundamental ratios, stakeholders can obtain critical insights into Castle Biosciences' financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Castle Biosciences is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
Last ReportedProjected for Next Year
Days Of Inventory On Hand 44.39  43.45 
Return On Tangible Assets 0.04  0.04 
Return On Capital Employed 0.02  0.02 
Return On Assets 0.03  0.03 
Return On Equity 0.05  0.04 

Things to note about Castle Biosciences performance evaluation

Checking the ongoing alerts about Castle Biosciences for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Castle Biosciences help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
Castle Biosciences generated a negative expected return over the last 90 days
Over 91.0% of the company shares are held by institutions such as insurance companies
Latest headline from finance.yahoo.com: Castle Biosciences Loses 16.8 percent in 4 Weeks, Heres Why a Trend Reversal May be Around the Corner
Evaluating Castle Biosciences' performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate Castle Biosciences' stock performance include:
  • Analyzing Castle Biosciences' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Castle Biosciences' stock is overvalued or undervalued compared to its peers.
  • Examining Castle Biosciences' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating Castle Biosciences' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Castle Biosciences' management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of Castle Biosciences' stock. These opinions can provide insight into Castle Biosciences' potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating Castle Biosciences' stock performance is not an exact science, and many factors can impact Castle Biosciences' stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.
When determining whether Castle Biosciences is a strong investment it is important to analyze Castle Biosciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Castle Biosciences' future performance. For an informed investment choice regarding Castle Stock, refer to the following important reports:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Castle Biosciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
For more information on how to buy Castle Stock please use our How to buy in Castle Stock guide.
You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Castle Biosciences. Projected growth potential of Castle fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Castle Biosciences assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth
(0.52)
Earnings Share
(0.44)
Revenue Per Share
11.977
Quarterly Revenue Growth
(0.03)
Return On Assets
(0.02)
The market value of Castle Biosciences is measured differently than its book value, which is the value of Castle that is recorded on the company's balance sheet. Investors also form their own opinion of Castle Biosciences' value that differs from its market value or its book value, called intrinsic value, which is Castle Biosciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Castle Biosciences' market value can be influenced by many factors that don't directly affect Castle Biosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Castle Biosciences' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Castle Biosciences should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Castle Biosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.